From: Management of hepatitis B infected pregnant women: a cross-sectional study of obstetricians
Knowledge | YES n(%) | NO n(%) | ra | P | |
---|---|---|---|---|---|
(Q13) Referral for chronic HBV management | |||||
(Q14) Complications of hepatitis B infection | correct | 80 (61.5) | 50 (38.5) | 0.05 | 0.520 |
incorrect | 4 (50.0) | 4 (50.0) | |||
(Q18) Risk of chronic HBV infection | correct | 21 (60.0) | 14 (40.0) | −0.01 | 0.904 |
incorrect | 63 (61.2) | 40 (38.8) | |||
Combination of Q14 + Q18 | correct | 20 (62.5) | 12 (37.5) | 0.02 | 0.831 |
incorrect | 64 (60.4) | 42 (39.6) | |||
(Q11) Monitoring of hepatitis B while pregnant | |||||
(Q17) Risk of newborn developing chronic infection | Correct | 33 (76.7) | 10 (23.3) | 0.18 | 0.033 |
Incorrect | 55 (57.9) | 40 (42.1) | |||
(Q6) Vaccination, HBIG | |||||
(Q17) Risk of newborn developing chronic infection | Correct | 38 (88.4) | 5 (11.6) | −0.03 | 0.700 |
Incorrect | 86 (90.5) | 9 (9.5) | |||
(Q7) Vaccination, Birth dose | |||||
(Q17) Risk of newborn developing chronic infection | Correct | 37 (86.0) | 6 (14.0) | −0.03 | 0.697 |
Incorrect | 84 (88.4) | 11 (11.6) | |||
(Q8) Vaccination, completion of series | |||||
(Q17) Risk of newborn developing chronic infection | Correct | 24 (55.8) | 19 (44.2) | 0.10 | 0.254 |
Incorrect | 43 (45.3) | 52 (54.7) | |||
(Q9) Vaccination, post vaccine serology testing | |||||
(Q17) Risk of newborn developing chronic infection | correct | 10 (23.3) | 33 (76.7) | 0.05 | 0.563 |
incorrect | 18 (18.9) | 77 (81.1) |